Dorsch Marion 4
4 · Blueprint Medicines Corp · Filed Feb 24, 2021
Insider Transaction Report
Form 4
Dorsch Marion
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2021-02-22$37.11/sh+7,578$281,220→ 22,828 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-02-22−7,578→ 40,422 totalExercise: $37.11Exp: 2026-11-21→ Common Stock (7,578 underlying) - Sale
Common Stock
2021-02-22$100.00/sh−7,578$757,800→ 15,250 total
Footnotes (2)
- [F1]Effected pursuant to a trading plan adopted on April 3, 2019 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- [F2]This option was granted on November 21, 2016. This option vested with respect to 25% of the shares underlying the option on November 21, 2017 and vests as to an additional 1/48th of the shares underlying the option each month thereafter.